Epidemiology and antifungal susceptibility of Candida species isolated from hospitalized patients

A. Kalkanci; E. Berk; Aykan, Şadiye Berna; K. Caglar; K. Hizel; D. Arman; S. Kustimur

dc.contributor.authors	Kalkanci, A; Berk, E; Aykan, B; Caglar, K; Hizel, K; Arman, D; Kustimur, S;
dc.date.accessioned	2020-01-20T07:57:11Z
dc.date.available	2020-01-20T07:57:11Z
dc.date.issued	2007
dc.identifier.citation	Kalkanci, A; Berk, E; Aykan, B; Caglar, K; Hizel, K; Arman, D; Kustimur, S; (2007). Epidemiology and antifungal susceptibility of Candida species isolated from hospitalized patients. , 17, 20-16
dc.identifier.issn	1156-5233
dc.identifier.uri	https://hdl.handle.net/20.500.12619/31902
dc.description.abstract	Conclusion: Amphotericin B is stilt the major therapeutic agent for azole resistant Candida and caspofungin seems to be a good alternative. (c) 2006 Elsevier Masson SAS. All rights reserved.
dc.description.uri	https://doi.org/10.1016/j.mycmed.2006.11.003
dc.language	English
dc.publisher	MASSON EDITEUR
dc.title	Epidemiology and antifungal susceptibility of Candida species isolated from hospitalized patients
dc.type	Article
dc.identifier.volume	17
dc.identifier.startpage	16
dc.identifier.endpage	20
dc.contributor.department	Sakarya Üniversitesi/Sağlık Hizmetleri Meslek Yüksekokulu/Tıbbi Hizmetler Ve Teknikler Bölümü
dc.contributor.saüauthor	Aykan, Şadiye Berna
dc.identifier.wos	WOS:000245772400003
dc.identifier.doi	10.1016/j.mycmed.2006.11.003
dc.contributor.author	A. Kalkanci
dc.contributor.author	E. Berk
dc.contributor.author	Aykan, Şadiye Berna
dc.contributor.author	K. Caglar
dc.contributor.author	K. Hizel
dc.contributor.author	D. Arman
dc.contributor.author	S. Kustimur